GPC1 and pancreatic neoplasm: As an illustrative example, the Kalluri group discovered that glypican 1 (GPC1)+ exosomes carrying the KRAS mutation in pancreatic cancer patients precisely mirrored mutations found in the tumor tissues, underscoring the heightened specificity exosomes can offer over traditional serum or plasma measurements.